Aridis Pharmaceuticals Inc (ARDS)

Trade ARDS now with
3/28/2019 4:12:00 PM Aridis Pharmaceuticals Q4 Loss/share $0.67 Vs. Loss $34.34 Year Ago
12/12/2018 7:34:53 AM Aridis : AR-501 Enrolls First Subject In Phase 1/2a Trial For Treatment Of Chronic Lung Infections In CF Patients
11/7/2018 7:35:19 AM Aridis Pharma Publishes Positive AR-301 Phase 1/2a Data In Intensive Care Medicine And The Lancet Respiratory Medicine
8/13/2018 12:29:24 AM This Week's Biotech IPOs